Literature DB >> 15081343

Lipophilic 4-imidazoly-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure.

Latifeh Navidpour1, Hamed Shafaroodi, Ramin Miri, Ahmad Reza Dehpour, Abbas Shafiee.   

Abstract

A group of alkyl, cycloalkyl and aryl ester analogs of nifedipine, in which the o-nitrophenyl group at position 4 is replaced by a 2-phenyl-4(5)-imidazolyl substituent, were synthesized and evaluated as calcium channel antagonist using the high K+ contraction of guinea-pig ileal longitudinal smooth muscle, and the activity of 5a-d, 8b and 8f against pentylenetetrazole (PTZ)-induced seizure was assessed. The results for symmetrical esters showed that lengthening of the methylene chain in C3 and C5 ester substituents increased activity. When increasing of the length is accompanied by increasing the hindrance, the activity decreased. In contrast to symmetrical derivatives, comparison of the activities of asymmetrical esters showed that increasing the length of the methylene chain was accompanied by a decrease in their activity. The results demonstrate that 8a was more active, and 5c and 8f were similar in effect to that of the reference drug nifedipine. The time-course of anticonvulsant effect on PTZ-induced seizure threshold of said compounds was assessed and showed that increasing the lipophilicity decreases the time needed for maximum effect. Mice treated with intraperitoneal injection of 25 mg/kg of these derivatives all exhibited increase seizure threshold as compared with control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081343     DOI: 10.1016/j.farmac.2003.11.013

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  5 in total

1.  Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.

Authors:  Arefeh Shafie; Maryam Mohammadi-Khanaposhtani; Mehdi Asadi; Nastaran Rahimi; Parviz Rashidi Ranjbar; Jahan B Ghasemi; Bagher Larijani; Mohammad Mahdavi; Hamed Shafaroodi; Ahmad Reza Dehpour
Journal:  Mol Divers       Date:  2019-03-20       Impact factor: 2.943

2.  Evaluation of anticonvulsant effect of two novels 4-[1-(4-fluorobenzyl)- 5-imidazolyl] dihydropyridine derivatives in mice.

Authors:  F Hadizadeh; B Rahimi; E Taghiabadi; M Razavi; G Karimi
Journal:  Res Pharm Sci       Date:  2013-04

3.  Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study.

Authors:  Omolbanin Shahraki; Najmeh Edraki; Mehdi Khoshneviszadeh; Farshid Zargari; Sara Ranjbar; Luciano Saso; Omidreza Firuzi; Ramin Miri
Journal:  Drug Des Devel Ther       Date:  2017-02-14       Impact factor: 4.162

4.  Involvement of nNOS, and α1, α2, β1, and β2 Subunits of Soluble Guanylyl Cyclase Genes Expression in Anticonvulsant Effect of Sumatriptan on Pentylenetetrazole-Induced Seizure in Mice.

Authors:  Faiza Mumtaz; Hamed Shafaroodi; Sadaf Nezamoleslami; Muhammad Zubair; Mohammad Sheibani; Vahid Nikoui; Mahmoud Ghazi-Khansari; Ahmad Reza Dehpour
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

5.  Oxidative Aromatization, Cytotoxic Activity Evaluation and Conformational Study of Novel 7-aryl-10, 11-dihydro-7H-chromeno [4, 3-b]quinoline-6, 8(9H, 12H)-dione Derivatives.

Authors:  Radineh Motamedi; Abbas Shafiee; Mohammad Reza Rezai; Omidreza Firuzi; Najmeh Edraki; Ramin Miri
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.